About Biovantix Biotechnology
Biovantix Biotechnology is a private company based in Dover, Delaware, incorporated in 2025 in Delaware. It has reported $0 raised in two offerings on Form D since October 2025. Its chief executive is Christian Carnes.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Not yet | Oct 17, 2025 | $0of $15.0M target | 0 | — | EquityRule 506(c) | Form D ↗ |
| Not yet | Oct 17, 2025 | $0of $15.0M target | 0 | — | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $0 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Biovantix Biotechnology's Form D filed Oct 17, 2025.
CC
Christian Carnes
Chief Executive Officer
On every Form D that Biovantix Biotechnology has filed: 2 filings, from Oct 17, 2025 to Oct 17, 2025.
JS
Jack Sunier
COO
On every Form D that Biovantix Biotechnology has filed: 2 filings, from Oct 17, 2025 to Oct 17, 2025.
EV
Elena Verutina
Chief People Officer
On every Form D that Biovantix Biotechnology has filed: 2 filings, from Oct 17, 2025 to Oct 17, 2025.